What are the Effects of Prostacyclin Sodium Tablets?

Prostaglandin Sodium Tablets are a common medication that has an improving and therapeutic effect on arterial occlusive diseases. When patients suffer from chronic arterial occlusive diseases, it is easy to cause ulcers, pain, and intermittent claudication. At this time, patients can use Prostaglandin Sodium Tablets under the guidance of doctors for treatment. Then what are the effects of Prostaglandin Sodium Tablets? And when should they be contraindicated? Let's take a brief look below.

I. Effects of Prostaglandin Sodium Tablets

Beraprost Sodium can inhibit platelet aggregation and adhesion, dissolve human platelet aggregates, increase oxygen partial pressure in tissues, shorten ischemia recovery time, and increase blood flow in various organ vessels. It is an effective drug for relieving chronic arterial occlusive diseases. It is recommended that patients take it as prescribed by their doctors and do not take it themselves.

Advice and Suggestions: Patients with chronic arterial occlusive diseases can increase collateral circulation through appropriate exercise, but please note to avoid lifting heavy objects and smoking.

II. Contraindications

1. Pregnant women or women who may be pregnant should not take this medication (the safety of using this medication during pregnancy has not been determined).

2. Patients with bleeding (such as hemophilia, capillary fragility, upper gastrointestinal bleeding, urinary bleeding, hemoptysis, fundus hemorrhage, etc.) should not take this medication as it may increase bleeding.

III. Serious Adverse Reactions

(1) Bleeding tendency [cerebral hemorrhage (less than 0.1%), gastrointestinal bleeding (less than 0.1%), lung bleeding (incidence unknown), fundus hemorrhage (less than 0.1%)]: Close observation is required. If abnormalities occur, the medication should be stopped, and appropriate treatment should be given.

(2) Shock (less than 0.1%): There have been reports of shock. Close observation is required. If symptoms such as decreased blood pressure, increased heart rate, pallor, nausea, etc. are observed, the medication should be stopped, and appropriate treatment should be given.

(3) Interstitial pneumonia (incidence unknown): There have been reports of interstitial pneumonia. Close observation is required. If abnormalities occur, the medication should be stopped, and appropriate treatment should be given.

(4) Low liver function (incidence unknown): There have been reports of liver function abnormalities such as jaundice and elevated GOT, GPT. Close observation is required. If abnormalities occur, the medication should be stopped, and appropriate treatment should be given.